Author

V. Chew

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Approach:experimental assay· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

J. Chen· 2 shared S. Lim· 2 shared W. Q. Leow· 2 shared A. Chung· 1 shared A. Larbi· 1 shared A. Prawira· 1 shared A. Singhal· 1 shared A. Tay· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. Chen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Single-cell and spatial atlas of steatotic liver-related hepatocellular carcinoma

A. Prawira, H. Xu, W. Q. Leow, M. Otsuka, Z. Chen, M. Rahbari, S. N. Hazirah, M. Wasser, A. Chung, B. K. P. Goh, P. K.-H. Chow, S. Albani, J. Lee, T. Lim, W. Zhai, , V. Chew

This study characterizes the tumor microenvironment of steatotic liver-related hepatocellular carcinoma using single-cell and spatial transcriptomic analyses, identifying immunosuppressive features and Treg-CAF interactions linked to immunotherapy resistance.

bioRxiv · May 9, 2024 · PreprintImmunology

Proliferative and quiescent human gastric cancer stem-like cells are associated with differential chemoresistance and patient mortality

K. S. Ang, H. K. Lee, M. Chevrier, M. Goh, J. Ling, V. Koh, X. Zhang, J. C. Tan, N. Lee, S. Erdal Irac, Z. M. Lim, J. Lum, A. Tay, C. Antoine Dutertre, C. Tang, , J. Chen

This study identifies two stem-like gastric cancer subpopulations with distinct chemoresistance and survival outcomes using scRNA-seq and organoid models.

bioRxiv · Oct 23, 2020 · PreprintImmunology

CD38 is a good predictor of anti-PD-1 immunotherapy responsiveness in hepatocellular carcinoma

S. Goh, H. H. M. Ng, V. Chew, X. N. Sim, H. Li, S. Lim, J. C. T. Lim, J. J. H. Loh, K. Sabai, C. C. H. Ong, T. Loh, W. Q. Leow, J. J. X. Lee, H. C. Toh, F. Malavasi, , T. K. H. Lim

The paper shows CD38 expression in immune infiltrates predicts response to anti-PD-1 immunotherapy in HCC patients.

bioRxiv · May 15, 2019 · PreprintCancer Biology